#Sweden #Stockholm #Skin Health #SciBase #EIS Technology

The Pioneering Role of SciBase's EIS Technology in Dermatological Research

SciBase Holding AB, a prominent player in AI-driven dermatological technology, has announced an exciting new collaboration with the National Institute of Health (NIH) in the United States. This partnership will leverage SciBase's innovative Electrical Impedance Spectroscopy (EIS) technology as a primary endpoint in a forthcoming study aimed at examining the effects of environmental exposures on skin health. The study, titled THREAT (Testing Harms Related to Exposure to Allergenic Toxins), is anticipated to provide critical insights into how everyday materials can affect skin barrier function.

Understanding the Study's Objectives

The upcoming NIH study is designed to explore the impact of common skin products and materials, including those that contain sodium lauryl sulfate (SLS), on healthy individuals. Participants will be exposed to various substances, including synthetic fibers found in clothing and bedding, as well as SLS-free and natural fiber alternatives like 100% cotton. The research aims to measure these exposures' effects on skin barrier dysfunction using skin impedance, a non-invasive method that detects changes in the skin's electrical properties. This approach reflects the health of the skin barrier and helps identify potential risks linked to environmental factors.

The collaboration highlights the crucial role that EIS technology can play in dermatology and beyond, paving the way for further research in clinical and cosmetic applications. By employing skin impedance as a primary endpoint, the study aims to quantify how different environmental influences can affect skin health in everyday life.

Study Details and Participation

The research will involve a cohort of 80 healthy volunteers who will experience two contradicting sets of environmental exposures. On the one hand, some participants will use products containing SLS and wear synthetic textiles. On the other hand, the control group will be exposed to SLS-free products and natural fibers. Throughout the study, the changes in skin barrier function will be evaluated, revealing any adverse effects associated with commonly used products.

Incorporating additional biomarkers alongside EIS measurements will provide a comprehensive analysis of the interactions between external exposures and skin health, encompassing molecular and inflammatory responses. These aspects could inform future guidelines in skincare product development and recommend safer, non-irritating alternatives for consumers.

The Broader Implications for Dermatology

SciBase's groundbreaking technology and its application in this study signify a pivotal moment for dermatological research. As explained by Pia Renaudin, CEO of SciBase, the selection of their Nevisense technology for this NIH-led initiative underscores the significance of objective assessments in evaluating skin barrier function. Renaudin expressed excitement about the collaboration and highlighted that this development would help expand the reach of their technology in dermatology and skin health assessment.

Potential Applications
The implications of SciBase's EIS technology go beyond just academic research. The insights gleaned from this study may open doors for new dermatological treatments, enhanced skincare products, and improved clinical practices focused on skin health. This research could also significantly influence industry standards for skin care and product safety, providing a scientific basis for recommendations that could lower the incidence of skin-related conditions linked to environmental irritants.

Conclusion

SciBase's commitment to advancing technologies for dermal assessment is at the forefront of medical innovation. As research progresses, it is expected to yield valuable data that could transform how consumers and healthcare providers perceive the relationship between skin health and environmental factors. This study not only seeks to advance scientific understanding but also aims to mitigate skin health risks, safeguard consumer well-being, and enhance the standard of skincare products available on the market.

For more information about the study and to access the editorial detailing the research approach, consider visiting the official NIH website or check the journal, Allergy, where findings from this collaboration will be published.